Silk Road Medical Inc
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Silk Road Medical Inc
The annual J.P. Morgan Healthcare Conference includes presentations from many major medtech companies outlining their growth strategies and expectations for 2021. Here are some of the highlights from the second day of the meeting.
Partner Therapeutics takes on Sanofi's immunostimulant. Novartis transitions struggling Arzerra for compassionate use only outside the US, with compensation to Genmab, while Shire licenses I.V. immunoglobulin candidate from AB Biosciences.
It's time for In Vivo's 10th annual Deals of the Year contest. We've selected 15 nominees in three categories – Top Alliance, Top Financing and Top M&A – and you get to pick the winners. (It's free.)
The bull run in medtech venture financing activity continued in July, with deal volume going up once again from the previous month. Deal value was also solid, boosted by a number of sizeable rounds that helped lift the total amount of venture dollars raised this year to date to $3.88bn. Barring the possibility of a sudden drought in the VC financing landscape in the next few months, 2017 should be in a good position to beat 2016 in total deal value.
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive